The role of WNT10B in physiology and disease : A 10-year update
Copyright © 2023 Perkins, Singh, Abell, Krum and Miranda-Carboni..
WNT10B, a member of the WNT family of secreted glycoproteins, activates the WNT/β-catenin signaling cascade to control proliferation, stemness, pluripotency, and cell fate decisions. WNT10B plays roles in many tissues, including bone, adipocytes, skin, hair, muscle, placenta, and the immune system. Aberrant WNT10B signaling leads to several diseases, such as osteoporosis, obesity, split-hand/foot malformation (SHFM), fibrosis, dental anomalies, and cancer. We reviewed WNT10B a decade ago, and here we provide a comprehensive update to the field. Novel research on WNT10B has expanded to many more tissues and diseases. WNT10B polymorphisms and mutations correlate with many phenotypes, including bone mineral density, obesity, pig litter size, dog elbow dysplasia, and cow body size. In addition, the field has focused on the regulation of WNT10B using upstream mediators, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). We also discussed the therapeutic implications of WNT10B regulation. In summary, research conducted during 2012-2022 revealed several new, diverse functions in the role of WNT10B in physiology and disease.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Frontiers in cell and developmental biology - 11(2023) vom: 09., Seite 1120365 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Perkins, Rachel S [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bone |
---|
Anmerkungen: |
Date Revised 24.02.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fcell.2023.1120365 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM353208663 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM353208663 | ||
003 | DE-627 | ||
005 | 20231226055459.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fcell.2023.1120365 |2 doi | |
028 | 5 | 2 | |a pubmed24n1177.xml |
035 | |a (DE-627)NLM353208663 | ||
035 | |a (NLM)36814601 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Perkins, Rachel S |e verfasserin |4 aut | |
245 | 1 | 4 | |a The role of WNT10B in physiology and disease |b A 10-year update |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 24.02.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2023 Perkins, Singh, Abell, Krum and Miranda-Carboni. | ||
520 | |a WNT10B, a member of the WNT family of secreted glycoproteins, activates the WNT/β-catenin signaling cascade to control proliferation, stemness, pluripotency, and cell fate decisions. WNT10B plays roles in many tissues, including bone, adipocytes, skin, hair, muscle, placenta, and the immune system. Aberrant WNT10B signaling leads to several diseases, such as osteoporosis, obesity, split-hand/foot malformation (SHFM), fibrosis, dental anomalies, and cancer. We reviewed WNT10B a decade ago, and here we provide a comprehensive update to the field. Novel research on WNT10B has expanded to many more tissues and diseases. WNT10B polymorphisms and mutations correlate with many phenotypes, including bone mineral density, obesity, pig litter size, dog elbow dysplasia, and cow body size. In addition, the field has focused on the regulation of WNT10B using upstream mediators, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). We also discussed the therapeutic implications of WNT10B regulation. In summary, research conducted during 2012-2022 revealed several new, diverse functions in the role of WNT10B in physiology and disease | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a WNT10B | |
650 | 4 | |a Wnt | |
650 | 4 | |a Wnt signaling | |
650 | 4 | |a bone | |
650 | 4 | |a cancer | |
650 | 4 | |a development | |
650 | 4 | |a disease | |
700 | 1 | |a Singh, Rishika |e verfasserin |4 aut | |
700 | 1 | |a Abell, Amy N |e verfasserin |4 aut | |
700 | 1 | |a Krum, Susan A |e verfasserin |4 aut | |
700 | 1 | |a Miranda-Carboni, Gustavo A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in cell and developmental biology |d 2013 |g 11(2023) vom: 09., Seite 1120365 |w (DE-627)NLM240031415 |x 2296-634X |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2023 |g day:09 |g pages:1120365 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fcell.2023.1120365 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2023 |b 09 |h 1120365 |